Genital Neoplasms, Male
Also known as: Male reproductive tract neoplasm / Neoplasm of male genital organ (disorder) / Male reproductive tract neoplasm NOS
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB04974 | Rimiducid | 1 | Active Not Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Completed | 1 |
| DB00441 | Gemcitabine | 2 | Completed | 1 |
| DB00619 | Imatinib | 2 | Completed | 1 |
| DB17120 | Imifoplatin | 2 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB04845 | Ixabepilone | 2 | Terminated | 1 |
| DB13982 | Lutetium Lu-177 | 2 | Active Not Recruiting | 1 |
| DB16778 | Lutetium Lu-177 vipivotide tetraxetan | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Terminated | 1 |
| DB09037 | Pembrolizumab | 2 | Terminated | 1 |
| DB14805 | Piflufolastat F 18 | 2 | Active Not Recruiting | 1 |
| DB05812 | Abiraterone | Not Available | Approved for Marketing | 1 |
| DB00860 | Prednisolone | Not Available | Approved for Marketing | 1 |
| DB00635 | Prednisone | Not Available | Approved for Marketing | 1 |